FDA inspection information is often spread across multiple databases, establishment profiles, inspection records, citation tables, Form 483 postings, Warning Letters, and other public sources. The Hopestone FDA Inspection & Form 483 Analyzer brings this information together into a single regulatory-intelligence workspace.

The analyzer helps Quality and Regulatory professionals research a company’s FDA inspection history, identify registered establishments, review classification trends, examine FDA citation details, evaluate available public records, and prepare requests for records that are not publicly available.

Key capabilities

The analyzer can help users:

• Search for FDA-related companies and registered establishments.
• Confirm facility names, FEI numbers, addresses, owner/operator relationships, and registered activities.
• Review inspection history by establishment and reporting period.
• Analyze NAI, VAI, and OAI classification trends.
• View an interactive inspection timeline.
• Review FDA inspection citation details and CFR references.
• Identify publicly available Form 483s, Warning Letters, and related records.
• Compare nearby FDA inspection activity by distance, lookback period, and product type.
• Research a specifically named FDA investigator using available FDA and HHS public records.
• Generate an AI-assisted inspection Analysis Brief.
• Identify evidence gaps and historically observed regulatory themes.
• Prepare FOIA request language for missing Form 483s, EIRs, and related inspection records.
• Export inspection history, reviewed observations, summaries, and analysis briefs.

AI-assisted inspection intelligence

The Inspection Intelligence section combines the selected facility’s inspection history, classifications, citation records, reviewed observations, public-record gaps, and other available evidence.

Users can select Generate Analysis Brief to create an evidence-grounded regulatory summary covering:

• Inspection chronology
• Classification trajectory
• Recurring citation themes
• Regulatory escalation signals
• Latest known inspection status
• Historically observed focus areas
• Missing evidence and recommended actions
• Important limitations in the available public record

The AI is instructed to rely only on evidence supplied by the analyzer and to distinguish verified facts from analytical interpretation.

Designed for regulatory research

The analyzer may support:

• FDA inspection preparation
• Management Review
• Regulatory intelligence
• Due diligence
• Competitive and peer research
• Historical compliance assessment
• Public-record gap analysis
• FOIA planning

The tool does not predict the identity of a future FDA investigator, the precise scope of an inspection, or the outcome of future FDA activity.

Launch the analyzer